Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

Mercuri, E.; Finkel, R.S.; Muntoni, F.; Wirth, B.; Montes, J.; Main, M.; Mazzone, E.S.; Vitale, M.; Snyder, B.; Quijano-Roy, S.; et al.

Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic

and Nutritional Care. Neuromuscul. Disord. 2018, 28, 103–115. [CrossRef] [PubMed]

Nurputra, D.K.; Lai, P.S.; Harahap, N.I.F.; Morikawa, S.; Yamamoto, T.; Nishimura, N.; Kubo, Y.; Takeuchi, A.; Saito, T.; Takeshima,

Y.; et al. Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials: SMA Gene Discovery to Clinical Trials. Ann. Hum.

Genet. 2013, 77, 435–463. [CrossRef] [PubMed]

Verhaart, I.E.C.; Robertson, A.; Wilson, I.J.; Aartsma-Rus, A.; Cameron, S.; Jones, C.C.; Cook, S.F.; Lochmüller, H. Prevalence,

Incidence and Carrier Frequency of 5q–Linked Spinal Muscular Atrophy—A Literature Review. Orphanet. J. Rare Dis. 2017, 12,

124. [CrossRef] [PubMed]

Rouzier, C.; Chaussenot, A.; Paquis-Flucklinger, V. Molecular Diagnosis and Genetic Counseling for Spinal Muscular Atrophy

(SMA). Arch. Pédiatr. 2020, 27, 7S9–7S14. [CrossRef]

Kimizu, T.; Ida, S.; Okamoto, K.; Awano, H.; Niba, E.T.E.; Wijaya, Y.O.S.; Okazaki, S.; Shimomura, H.; Lee, T.; Tominaga, K.; et al.

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan. IJNS 2021, 7, 45. [CrossRef] [PubMed]

Arnold, W.D.; Kassar, D.; Kissel, J.T. Spinal Muscular Atrophy: Diagnosis and Management in a New Therapeutic Era: Spinal

Muscular Atrophy. Muscle Nerve 2015, 51, 157–167. [CrossRef] [PubMed]

Melki, J.; Abdelhak, S.; Sheth, P.; Bachelot, M.F.; Burlet, P.; Marcadet, A.; Aicardi, J.; Barois, A.; Carriere, J.P.; Fardeau, M.; et al.

Gene for Chronic Proximal Spinal Muscular Atrophies Maps to Chromosome 5q. Nature 1990, 344, 767–768. [CrossRef]

Lefebvre, S.; Bürglen, L.; Reboullet, S.; Clermont, O.; Burlet, P.; Viollet, L.; Benichou, B.; Cruaud, C.; Millasseau, P.; Zeviani, M.;

et al. Identification and Characterization of a Spinal Muscular Atrophy-Determining Gene. Cell 1995, 80, 155–165. [CrossRef]

Lorson, C.L.; Hahnen, E.; Androphy, E.J.; Wirth, B. A Single Nucleotide in the SMN Gene Regulates Splicing and Is Responsible

for Spinal Muscular Atrophy. Proc. Natl. Acad. Sci. USA 1999, 96, 6307–6311. [CrossRef] [PubMed]

Lorson, C.L. An Exonic Enhancer Is Required for Inclusion of an Essential Exon in the SMA-Determining Gene SMN. Hum. Mol.

Genet. 2000, 9, 259–265. [CrossRef] [PubMed]

Burnett, B.G.; Muñoz, E.; Tandon, A.; Kwon, D.Y.; Sumner, C.J.; Fischbeck, K.H. Regulation of SMN Protein Stability. Mol. Cell

Biol. 2009, 29, 1107–1115. [CrossRef] [PubMed]

Cho, S.; Dreyfuss, G. A Degron Created by SMN2 Exon 7 Skipping Is a Principal Contributor to Spinal Muscular Atrophy Severity.

Genes Dev. 2010, 24, 438–442. [CrossRef] [PubMed]

Wirth, B. An Update of the Mutation Spectrum of the Survival Motor Neuron Gene (SMN1) in Autosomal Recessive Spinal

Muscular Atrophy (SMA). Hum. Mutat. 2000, 15, 228–237. [CrossRef]

Sun, Y.; Grimmler, M.; Schwarzer, V.; Schoenen, F.; Fischer, U.; Wirth, B. Molecular and Functional Analysis of Intragenic SMN1

Mutations in Patients with Spinal Muscular Atrophy. Hum. Mutat. 2005, 25, 64–71. [CrossRef]

Wijaya, Y.O.S.; Ar Rohmah, M.; Niba, E.T.E.; Morisada, N.; Noguchi, Y.; Hidaka, Y.; Ozasa, S.; Inoue, T.; Shimazu, T.; Takahashi, Y.;

et al. Phenotypes of SMA Patients Retaining SMN1 with Intragenic Mutation. Brain Dev. 2021, 43, 745–758. [CrossRef] [PubMed]

Kirwin, S.M.; Vinette, K.M.B.; Gonzalez, I.L.; Abdulwahed, H.A.; Al-Sannaa, N.; Funanage, V.L. A Homozygous Double Mutation

in SMN 1: A Complicated Genetic Diagnosis of SMA. Mol. Genet. Genom. Med. 2013, 1, 113–117. [CrossRef] [PubMed]

Cuscó, I.; López, E.; Soler-Botija, C.; Jesús Barceló, M.; Baiget, M.; Tizzano, E.F. A Genetic and Phenotypic Analysis in Spanish

Spinal Muscular Atrophy Patients with c.399_402del AGAG, the Most Frequently Found Subtle Mutation in the SMN1 Gene:

Genotype-phenotype analysis in SMN1. Hum. Mutat. 2003, 22, 136–143. [CrossRef] [PubMed]

Fraidakis, M.J.; Drunat, S.; Maisonobe, T.; Gerard, B.; Pradat, P.F.; Meininger, V.; Salachas, F. Genotype-Phenotype Relationship in

2 SMA III Patients with Novel Mutations in the Tudor Domain. Neurology 2012, 78, 551–556. [CrossRef] [PubMed]

Yamamoto, T.; Sato, H.; Lai, P.S.; Nurputra, D.K.; Harahap, N.I.F.; Morikawa, S.; Nishimura, N.; Kurashige, T.; Ohshita, T.;

Nakajima, H.; et al. Intragenic Mutations in SMN1 May Contribute More Significantly to Clinical Severity than SMN2 Copy

Numbers in Some Spinal Muscular Atrophy (SMA) Patients. Brain Dev. 2014, 36, 914–920. [CrossRef] [PubMed]

Kotani, T.; Sutomo, R.; Sasongko, T.H.; Sadewa, A.H.; Gunadi; Minato, T.; Fujii, E.; Endo, S.; Lee, M.J.; Ayaki, H.; et al. A Novel

Mutation at the N-Terminal of SMN Tudor Domain Inhibits Its Interaction with Target Proteins. J. Neurol. 2007, 254, 624–630.

[CrossRef]

de Holanda Mendonça, R.; Matsui, C.; Polido, G.J.; Silva, A.M.S.; Kulikowski, L.; Torchio Dias, A.; Zanardo, E.A.; Solla, D.J.F.;

Gurgel-Giannetti, J.; de Moura, A.C.M.L.; et al. Intragenic Variants in the SMN1 Gene Determine the Clinical Phenotype in 5q

Spinal Muscular Atrophy. Neurol. Genet. 2020, 6, e505. [CrossRef]

Takarada, T.; Ar Rochmah, M.; Harahap, N.I.F.; Shinohara, M.; Saito, T.; Saito, K.; Lai, P.S.; Bouike, Y.; Takeshima, Y.; Awano, H.;

et al. SMA Mutations in SMN Tudor and C-Terminal Domains Destabilize the Protein. Brain Dev. 2017, 39, 606–612. [CrossRef]

[PubMed]

Lorson, C.L.; Strasswimmer, J.; Yao, J.-M.; Baleja, J.D.; Hahnen, E.; Wirth, B.; Le, T.; Burghes, A.H.M.; Androphy, E.J. SMN

Oligomerization Defect Correlates with Spinal Muscular Atrophy Severity. Nat. Genet. 1998, 19, 63–66. [CrossRef] [PubMed]

Pellizzoni, L.; Charroux, B.; Dreyfuss, G. SMN Mutants of Spinal Muscular Atrophy Patients Are Defective in Binding to SnRNP

Proteins. Proc. Nat. Acad. Sci. USA 1999, 96, 11167–11172. [CrossRef] [PubMed]

Gupta, K.; Martin, R.; Sharp, R.; Sarachan, K.L.; Ninan, N.S.; Van Duyne, G.D. Oligomeric Properties of Survival Motor

Neuron·Gemin2 Complexes. J. Biol. Chem. 2015, 290, 20185–20199. [CrossRef] [PubMed]

Genes 2022, 13, 205

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

40.

41.

42.

43.

15 of 15

Wan, L.; Battle, D.J.; Yong, J.; Gubitz, A.K.; Kolb, S.J.; Wang, J.; Dreyfuss, G. The Survival of Motor Neurons Protein Determines

the Capacity for SnRNP Assembly: Biochemical Deficiency in Spinal Muscular Atrophy. Mol. Cell Biol. 2005, 25, 5543–5551.

[CrossRef] [PubMed]

Burghes, A.H.M.; Beattie, C.E. Spinal Muscular Atrophy: Why Do Low Levels of Survival Motor Neuron Protein Make Motor

Neurons Sick? Nat. Rev. Neurosci. 2009, 10, 597–609. [CrossRef] [PubMed]

Ar Rochmah, M.; Awano, H.; Awaya, T.; Harahap, N.I.F.; Morisada, N.; Bouike, Y.; Saito, T.; Kubo, Y.; Saito, K.; Lai, P.S.; et al.

Spinal Muscular Atrophy Carriers with Two SMN1 Copies. Brain Dev. 2017, 39, 851–860. [CrossRef] [PubMed]

Yamada, H.; Nishida, Y.; Maihara, T.; Sa’adah, N.; Harahap, N.I.F.; Nurputra, D.K.; Ar Rochmah, M.; Nishimura, N.; Saito, T.;

Kubo, Y.; et al. Two Japanese Patients With SMA Type 1 Suggest That Axonal-SMN May Not Modify the Disease Severity. Pediatr.

Neurol. 2015, 52, 638–641. [CrossRef]

Shpargel, K.B.; Matera, A.G. Gemin Proteins Are Required for Efficient Assembly of Sm-Class Ribonucleoproteins. Proc. Nat.

Acad. Sci. USA 2005, 102, 17372–17377. [CrossRef]

Harahap, N.I.F.; Niba, E.T.E.; Ar Rochmah, M.; Wijaya, Y.O.S.; Saito, T.; Saito, K.; Awano, H.; Morioka, I.; Iijima, K.; Lai, P.S.; et al.

Intron-Retained Transcripts of the Spinal Muscular Atrophy Genes, SMN1 and SMN2. Brain Dev. 2018, 40, 670–677. [CrossRef]

[PubMed]

Bürglen, L.; Lefebvre, S.; Clermont, O.; Burlet, P.; Viollet, L.; Cruaud, C.; Munnich, A.; Melki, J. Structure and Organization of the

Human Survival Motor Neurone (SMN) Gene. Genomics 1996, 32, 479–482. [CrossRef] [PubMed]

Rochmah, M.A.; Wijaya, Y.O.S.; Harahap, N.I.F.; Tode, C.; Takeuchi, A.; Ohuchi, K.; Shimazawa, M.; Hara, H.; Funato, M.; Saito, T.;

et al. Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients. Kobe J. Med. Sci. 2020, 66, E1–E11.

[PubMed]

Martin, R.; Gupta, K.; Ninan, N.S.; Perry, K.; Van Duyne, G.D. The Survival Motor Neuron Protein Forms Soluble Glycine Zipper

Oligomers. Structure 2012, 20, 1929–1939. [CrossRef] [PubMed]

Gupta, K.; Wen, Y.; Ninan, N.S.; Raimer, A.C.; Sharp, R.; Spring, A.M.; Sarachan, K.L.; Johnson, M.C.; Van Duyne, G.D.; Matera,

A.G. Assembly of Higher-Order SMN Oligomers Is Essential for Metazoan Viability and Requires an Exposed Structural Motif

Present in the YG Zipper Dimer. Nucleic Acids Res. 2021, 49, 7644–7664. [CrossRef]

Coady, T.H.; Lorson, C.L. SMN in Spinal Muscular Atrophy and SnRNP Biogenesis: SMN in Spinal Muscular Atrophy and

SnRNP Biogenesis. WIREs RNA 2011, 2, 546–564. [CrossRef]

Lee, M.-S.; Lin, Y.-S.; Deng, Y.-F.; Hsu, W.-T.; Shen, C.-C.; Cheng, Y.-H.; Huang, Y.-T.; Li, C. Modulation of Alternative Splicing by

Expression of Small Nuclear Ribonucleoprotein Polypeptide N. FEBS J. 2014, 281, 5194–5207. [CrossRef]

Akten, B.; Kye, M.J.; Hao, L.T.; Wertz, M.H.; Singh, S.; Nie, D.; Huang, J.; Merianda, T.T.; Twiss, J.L.; Beattie, C.E.; et al. Interaction

of Survival of Motor Neuron (SMN) and HuD Proteins with MRNA Cpg15 Rescues Motor Neuron Axonal Deficits. Proc. Nat.

Acad. Sci. USA 2011, 108, 10337–10342. [CrossRef] [PubMed]

Fallini, C.; Zhang, H.; Su, Y.; Silani, V.; Singer, R.H.; Rossoll, W.; Bassell, G.J. The Survival of Motor Neuron (SMN) Protein

Interacts with the MRNA-Binding Protein HuD and Regulates Localization of Poly(A) MRNA in Primary Motor Neuron Axons.

J. Neurosci. 2011, 31, 3914–3925. [CrossRef] [PubMed]

Hubers, L.; Valderrama-Carvajal, H.; Laframboise, J.; Timbers, J.; Sanchez, G.; Côté, J. HuD Interacts with Survival Motor Neuron

Protein and Can Rescue Spinal Muscular Atrophy-like Neuronal Defects. Hum. Mol. Genet. 2011, 20, 553–579. [CrossRef]

Hao le, T.; Duy, P.Q.; An, M.; Talbot, J.; Iyer, C.C.; Wolman, M.; Beattie, C.E. HuD and the Survival Motor Neuron Protein

Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and MRNA Regulation. J. Neurosci. 2017, 37,

11559–11571. [CrossRef] [PubMed]

Li, D.K.; Tisdale, S.; Lotti, F.; Pellizzoni, L. SMN Control of RNP Assembly: From Post-Transcriptional Gene Regulation to Motor

Neuron Disease. Semin. Cell Dev. Biol. 2014, 32, 22–29. [CrossRef] [PubMed]

Iyer, C.C.; Corlett, K.M.; Massoni-Laporte, A.; Duque, S.I.; Madabusi, N.; Tisdale, S.; McGovern, V.L.; Le, T.T.; Zaworski, P.G.;

Arnold, W.D.; et al. Mild SMN Missense Alleles Are Only Functional in the Presence of SMN2 in Mammals. Hum. Mol. Genet.

2018, 27, 3404–3416. [CrossRef] [PubMed]

...